191
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      scite_
       
      • Record: found
      • Abstract: found
      • Conference Proceedings: found
      Is Open Access

      Fair pricing in drug repurposing

      Published
      proceedings-article
        1 ,
      ScienceOpen
      RExPO22
      2-3 September, 2022
      Fair price medicines, transparent model, calculator
      Bookmark

            Abstract

            As the representative of not-for-profit healthcare payers in 28 countries, 18 of which in Europe, AIM is concerned about the evolution of recent drug prices and the risks they pose to the sustainability of solidarity-based healthcare systems. AIM has developed a model to set a Fair Price for new medicines that combines affordability and support to innovation. The model is based on objective parameters and takes into account the costs of bringing a drug to the market, the therapeutical value of the drug and allows reasonable profit for the pharmaceutical industry. The model offers an alternative starting point for price negotiations and calls for a comprehensive, open and transparent debate and a paradigm shift in the pricing of medicines. The price calculation is carried out by indication, which makes it particularly well suited to repurposed medicines. Since June 2021, AIM has made available a unique tool that allows to calculate the European fair price for each new drug, the European Fair Price Calculator, publicly accessible on its website.

            Content

            Author and article information

            Conference
            ScienceOpen
            26 August 2022
            Affiliations
            [1 ] Solidaris, on behalf of AIM (International Association of Mutual Benefit Societies), rue d'Arlon, 50B - 1000 Brussels (Belgium)
            Author notes
            Author information
            https://orcid.org/0000-0001-5433-3650
            Article
            10.14293/S2199-1006.1.SOR-.PPPSTOF6.v1
            19ddd69c-aaaf-4fa2-8978-f069d80c191b

            This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

            RExPO22
            Maastricht, Netherlands
            2-3 September, 2022
            History
            : 26 August 2022

            Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
            Fair price medicines, transparent model, calculator

            Comments

            Comment on this article